StockData

Delcath Systems vs IRadimed

DCTH and IRMD side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DCTH and IRMD compare

IRadimed is the larger company, worth 1.6 times as much as Delcath Systems ($1.1B against $672M).

On earnings, IRadimed is cheaper: it trades at 44.6× trailing earnings, against 1937× for Delcath Systems.

Delcath Systems grew revenue faster over the last twelve months (35.8% versus 11.0% for IRadimed).

IRadimed keeps more of each dollar of sales as profit, with a net margin of 26.8% compared with 0.56% at Delcath Systems.

IRadimed pays a dividend yielding 0.96%; Delcath Systems does not pay one.

IRadimed scores higher on the StockData Score (19 against 13 for Delcath Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDCTHIRMD
Size and price
Market cap$672M$1.1B
Share price$19.37$83.45
Change, 1 year117%−1.1%
Change, 5 years98.9%97.3%
Beta (5Y)1.98−0.02
Employees156166
StockData Score
Total score1319 (better)
Valuation score00
Growth score44
Performance score36 (better)
Health score66
Dividend score03 (better)
Valuation
P/E1937×44.6× (better)
P/S7.0× (better)11.9×
P/B5.5× (better)10.0×
EV/EBITDA–32.9×
P/FCF38.4× (better)40.8×
PEG–2.26
FCF yield2.6% (better)2.4%
Fair value–$54.03
Margin of safety–−54.4%
Growth
Revenue growth (TTM)35.8% (better)11.0%
Revenue growth, 5Y average–21.5%
Net income growth (TTM)−76.2%13.2% (better)
EPS growth (TTM)−80.0%13.3% (better)
EPS growth, 5Y average–73.9%
Profitability
Gross margin87.1% (better)75.5%
Operating margin−1.9%32.3% (better)
Net margin0.56%26.8% (better)
FCF margin18.3%29.3% (better)
Return on equity0.47%23.4% (better)
Return on invested capital−3.7%52.3% (better)
Financial health
Debt / equity0.000.00
Current ratio9.83 (better)8.99
Altman Z-score21.7047.01 (better)
Piotroski F-score7 (better)6
Dividends and buybacks
Dividend yield–0.96%
Payout ratio–67.6%
Buyback yield−0.09%–
Shareholder yield−0.09%0.96% (better)
Ownership
Held by institutions50.2%61.4%
Held by insiders37.4%35.5%
Insider net buying, 12 months−$338K (better)−$16.0M
Short interest, % of float8.2%7.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.